Search

Michael Thomas Chopp

from Warren, MI
Age ~68

Michael Chopp Phones & Addresses

  • 7502 Studebaker Ave, Warren, MI 48091
  • 114 W Adams Ave APT 803, Detroit, MI 48226
  • Sterling Heights, MI
  • Harrison Township, MI
  • Southfield, MI
  • Mount Clemens, MI
  • Las Vegas, NV

Resumes

Resumes

Michael Chopp Photo 1

Audio Technician

View page
Location:
10896 Ridge View Trl, Fenton, MI 48430
Industry:
Entertainment
Work:
Michigan Technological University Sep 2017 - May 2019
Mtu Athletics Head Broadcast Engineer

Michigan Technological University Sep 2016 - May 2019
Audio Video Technician

Lighthouse Productions_Wi Sep 2016 - May 2019
Audio Technician

Michigan Technological University Sep 2016 - Sep 2018
Broadcast Assistant

Lighthouse Productions_Wi May 2017 - Aug 2018
Internship
Education:
Michigan Technological University 2015 - 2019
Bachelors, Bachelor of Science
Skills:
Live Sound
Systems Design
Media Production
Camera Operation
Troubleshooting
Recording
Soldering
Audio Visual Systems
Pro Tools
Teamwork
Digital Audio
Sound Systems
Signal Flow
Cable Management
Crew Supervision
Communication Systems
Qlab
Yamaha Digital Consoles
Afmg Ease
Rational Acoustics Smaart
Dante Networking Technology
Audio Architect
Jbl Performance Manager
Jbl Line Array Calculator
Avid Venue Series Consoles
Midas Digital Consoles
Michael Chopp Photo 2

Engineer

View page
Location:
Detroit, MI
Industry:
Automotive
Work:
Gm Y1Xx and 31Xx 2011 - 2013
Dre

Yazaki North America 1994 - 2006
Supervisor Dfma

Tianhai Electric North America 1994 - 2006
Engineer
Michael Chopp Photo 3

Direct Careworker At Expertcare

View page
Location:
1200 east Savannah Ave, Mcallen, TX 78503
Industry:
Hospital & Health Care
Work:
Expertcare
Direct Careworker at Expertcare

Business Records

Name / Title
Company / Classification
Phones & Addresses
Michael Chopp
Human Resources Manager
Indiana Department of Insurance
General Government · Government Office · Executive Office · Regulation Misc Commercial Sector · Insurance Department Government
(317) 232-0143, (317) 232-5695, (317) 232-2410, (317) 233-4243

Publications

Us Patents

Nitric Oxide Donors For Inducing Neurogenesis

View page
US Patent:
7135498, Nov 14, 2006
Filed:
Jun 14, 2000
Appl. No.:
10/018201
Inventors:
Michael Chopp - Southfield MI, US
Rui Lan Zhang - Troy MI, US
Assignee:
Henry Ford Health System - Detroit MI
International Classification:
A01N 37/12
US Classification:
514565, 514482, 514611, 424422
Abstract:
There is provided a method of promoting neurogenesis by administering a therapeutic amount of a nitric oxide donor compound to a patient in need of neurogenesis promotion. Also provided is a compound for providing neurogenesis having an effective amount of a nitric oxide donor sufficient to promote neurogenesis. A nitric oxide compound for promoting neurogenesis is also provided. Further, a method of augmenting the production of brain cells and facilitating cellular structural and receptor changes by administering an effective amount of a nitric oxide donor compound to a site in need of augmentation is provided. There is provided method of increasing both neurological and cognitive function by administering an effective amount of a nitric oxide donor compound to a patient.

Nitric Oxide Donors For Inducing Neurogenesis

View page
US Patent:
7655423, Feb 2, 2010
Filed:
Feb 13, 2002
Appl. No.:
10/075715
Inventors:
Michael Chopp - Southfield MI, US
Rui Lan Zhang - Troy MI, US
Assignee:
Henry Ford Health System - Detroit MI
International Classification:
G01N 33/554
A61K 31/497
A01N 37/12
US Classification:
435 721, 51425214, 514565
Abstract:
There is provided a method of promoting neurogenesis by administering a therapeutic amount of a nitric oxide donor compound to a patient in need of neurogenesis promotion. Also provided is a compound for providing neurogenesis having an effective amount of a nitric oxide donor sufficient to promote neurogenesis. A nitric oxide compound for promoting neurogenesis is also provided. Further, a method of augmenting the production of brain cells and facilitating cellular structural and receptor changes by administering an effective amount of a nitric oxide donor compound to a site in need of augmentation is provided. There is provided a method of increasing both neurological and cognitive function by administering an effective amount of a nitric oxide donor compound to a patient.

Transplantation Of Bone Marrow Stromal Cells For Treatment Of Neurodegenerative Diseases

View page
US Patent:
8017112, Sep 13, 2011
Filed:
May 9, 2006
Appl. No.:
11/431290
Inventors:
Yi Li - Canton MI, US
Michael Chopp - Southfield MI, US
Assignee:
Henry Ford Health System - Detroit MI
International Classification:
C12N 5/071
C12N 5/0797
C12N 5/22
US Classification:
424 937, 435377
Abstract:
The present invention relates to a treatment of an autoimmune demyelinating disease/disorder. Also included in the present invention is the use of bone marrow stromal cells for the treatment of multiple sclerosis (MS).

Nitric Oxide Donors For Inducing Neurogenesis

View page
US Patent:
8383626, Feb 26, 2013
Filed:
Feb 1, 2010
Appl. No.:
12/697790
Inventors:
Michael Chopp - Southfield MI, US
Rui Lan Zhang - Troy MI, US
Assignee:
Henry Ford Health System - Detroit MI
International Classification:
A61K 31/497
A01N 37/12
US Classification:
51425214, 514565
Abstract:
There is provided a method of promoting neurogenesis by administering a therapeutic amount of a nitric oxide donor compound to a patient in need of neurogenesis promotion. Also provided is a compound for providing neurogenesis having an effective amount of a nitric oxide donor sufficient to promote neurogenesis. A nitric oxide compound for promoting neurogenesis is also provided. Further, a method of augmenting the production of brain cells and facilitating cellular structural and receptor changes by administering an effective amount of a nitric oxide donor compound to a site in need of augmentation is provided. There is provided a method of increasing both neurological and cognitive function by administering an effective amount of a nitric oxide donor compound to a patient.

Nitric Oxide Donors For Treatment Of Disease And Injury

View page
US Patent:
20050143388, Jun 30, 2005
Filed:
Jan 6, 2003
Appl. No.:
10/500694
Inventors:
Michael Chopp - Detroit MI, US
International Classification:
A61K031/519
US Classification:
514252160, 514262100
Abstract:
A method of promoting neurogenesis by administering a therapeutic amount of a phosphodiesterase inhibitor compound is a patient in need of neurogenesis promotion. A compound for providing neurogenesis having an effective amount of a phosphodiesterase inhibitor sufficient to promote neurogenesis. A phosphodiesterase inhibitor for promoting neurogenesis. A method of augmenting the production of brain cells and facilitating cellular structual and receptor changes by administering an effective amount of a phosphodiesterase inhibitor compound to a site in need of augmentation. A method of increasing both neurological and cognitive function by administering an effective amount of a phosphodiesterase inhibitor compound to a patient.

Materials From Bone Marrow Stromal Cells For Use In Forming Blood Vessels And Producing Angiogenic And Trophic Factors

View page
US Patent:
20050158397, Jul 21, 2005
Filed:
Jan 14, 2003
Appl. No.:
10/502723
Inventors:
Michael Chopp - Southfield MI, US
Yi Li - Canton MI, US
Xiaoguang Chen - Madison Heights MI, US
International Classification:
A61K035/30
A61K035/00
C12P021/04
US Classification:
424570000, 424115000, 424093700, 435070300
Abstract:
A therapeutic for use in inducing angiogenesis and vasculogenesis, the therapeutic including angiogenesis and vasculogenesis inducing factors isolated from stem cells in conjunction with a pharamaceutically acceptable cell therapy. A method of amplifying the production of angiogenesis and vasculogenesis inducing factors secreted by exposing stem cells to and co-culturing the stem cells with a compound for increasing the production of angiogenesis and vasculogenesis inducing factors. Angiogenesis and vasculogenesis inducing factors isolated and purified from stem cells for use in a therapy. A process for obtaining the angiogenesis and vasculogenesis inducing factors as set forth above, the process including the steps of isolating and purifying human mesenchymal stem cells from tissue prior to differentiation and then culture expanding the mesenchymal stem cells to produce a tool for neurological and musculoskeletal therapy. Isolated and culture expanded mesenchymal stem cells under the influence of a requisite compound, that are capable of differentiating and producing a desired cell phenotype needed for tissue repair.

Bone Marrow Transplantation For Treatment Of Stroke

View page
US Patent:
20050169896, Aug 4, 2005
Filed:
Dec 30, 2004
Appl. No.:
11/027881
Inventors:
Yi Li - Canton MI, US
Michael Chopp - Southfield MI, US
International Classification:
A61K045/00
US Classification:
424093700
Abstract:
The present invention relates to a treatment of neural injury and neurodegenerative diseases. Also included in the present invention is the use of stromal cells for the treatment of neural injury (stroke, traumatic brain injury, spinal cord injury) and neurodegeneration (i.e. Parkinson's disease).

Stem Cells For Use In Locating And Targeting Tumor Cells

View page
US Patent:
20060159623, Jul 20, 2006
Filed:
Jan 3, 2006
Appl. No.:
11/324978
Inventors:
Michael Chopp - Detroit MI, US
Zhenggang Zhang - Detroit MI, US
International Classification:
A61K 49/00
A61K 48/00
C12N 5/08
US Classification:
424009200, 424093210, 435366000, 424009340
Abstract:
A composition for locating tumors, the composition includes stem cells. Stem cells for use in locating and treating tumors. A method of locating and treating a tumor by administering to a patient an effective amount of stem cells, wherein the stem cells locate and subsequently treat a tumor.
Michael Thomas Chopp from Warren, MI, age ~68 Get Report